Saturday 17 October 2026
Export POM’s income statement to Excel — free account
Pomdoctor Limited - Sponsored ADR
POM Healthcare Pharmaceutical Retailers
Pomdoctor Limited - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $57.2 million, up 21.9% from fiscal 2024.
0.61
0.10
−14.08%
Follow POM
| Dec '24 | Dec '25 | |
|---|---|---|
Altman Z-Score |
— | (33.29) |
Altman Z″-Score (non-manufacturers) |
(184.50) | (90.22) |
Beneish M-Score |
— | 0.80 |
P/Operating CF |
0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 |
Quick Ratio |
0.15 | 0.44 |
Current Ratio |
0.21 | 0.48 |
Net Debt/EBITDA |
(16.77) | (3.73) |
Debt/Assets |
947.57% | 420.33% |
Debt/Equity |
(0.19) | (0.94) |
Asset Turnover |
0.00 | 5.27 |
Operating CF/Net income |
0.11 | 0.70 |
Capex/Depreciation |
(0.25) | (6.73) |
Interest Coverage |
(1.99) | (9.21) |
| 0.00% | 16.05% | |
| 0.00% | (279.99%) | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
101.54% | 189.88% |
Average Days of Receivables |
21.04 | 78.88 |
Research and Development Expense of Revenue |
0.88% | 3.22% |
Selling, General and Administrative Expense of Revenue |
19.92% | 38.99% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 4.11% |
Graham Net Nets |
0.00 | 0.00 |
Graham Number |
0.00 | 0.00 |
Free Cash Flow per Share |
(1.05) | (6.63) |
Cash per Share |
0.50 | 0.43 |
Shareholders Equity per Share |
(147.58) | (21.35) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(147.58) | (21.35) |
Free Cash Flow |
(2.21) | (21.38) |
Working Capital |
(19.41) | (16.19) |
Capital Expenditures |
0.00 | (0.14) |
Net Current Asset Value |
(311.28) | (69.19) |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
0.29 | 0.12 |
Cash ROIC |
0.89% | 762.08% |
Accounts Receivable Turnover |
0.00 | 7.59 |
Accounts Payable Turnover |
0.00 | 10.06 |
Inventory Turnover |
0.00 | 40.75 |
Average Days of Payables |
31.37 | 47.06 |
Days of Inventory on Hand |
11.35 | 8.69 |
Revenue per Share |
22.34 | 17.74 |
Operating CF per Share |
(1.05) | (6.59) |
Capex per Share |
0.00 | (0.04) |
Average Receivables |
— | 7.53 |
Average Payables |
— | 4.94 |
Average Inventory |
— | 1.22 |
Average Assets |
— | 10.86 |
Average Common Equity |
— | (189.45) |
Columns are period end dates · fundamentals updated 1 Oct 2026